Skip to main content
NUS logo

NUS · Nu Skin Enterprises, Inc. · Webcasts, Transcripts & Audio

Track NUS — free
$4.72 +0.09 (+1.84%)
Market Cap
$225.37M
Shares
48.68M
Volume · Oct 6 208.86K Avg daily vol (3M) 562.82K

Nu Skin Enterprises, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Nu Skin Enterprises, Inc. (NUS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q2
2026-08-10
Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript
Balanced tone Sales force and leadership development India market entry delay Anti-aging innovation and science
Revenue
$320.11M
▼ 17.1% YoY
Diluted EPS
$-5.14
▼ 1295.3% YoY
Gross margin
68.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Nu Skin Enterprises, Inc. (NUS) Q1 2026 Earnings Call Transcript
Positive tone Prysm iO Platform Launch Macroeconomic and Tariff Headwinds Emerging Markets Expansion
Revenue
$320.61M
▼ 12% YoY
Diluted EPS
$0.04
▼ 98.1% YoY
Gross margin
66.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-12
Nu Skin Enterprises, Inc. (NUS) Q4 2025 Earnings Call Transcript
Positive tone Prism IO intelligent wellness platform India market entry 2026 guidance and revenue outlook
Revenue
$370.32M*
▼ 16.9% YoY
Gross margin
70.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Nu Skin Enterprises, Inc. (NUS) Q3 2025 Earnings Call Transcript
Positive tone Prysm iO intelligent wellness platform launch India market expansion Financial discipline and profitability
Revenue
$364.21M
▼ 15.3% YoY
Diluted EPS
$0.34
▲ 100% YoY
Gross margin
70.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Nu Skin Enterprises, Inc. (NUS) Q2 2025 Earnings Call Transcript
Confident tone Prysm iO Intelligent Wellness Platform Developing Markets / Latin America Growth India Market Entry
Revenue
$386.14M
▼ 12.1% YoY
Diluted EPS
$0.43
Gross margin
68.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Nu Skin Enterprises, Inc. (NUS) Q1 2025 Earnings Call Transcript
Positive tone Prysm iO intelligent wellness platform Sales compensation plan and core business Macroeconomic and tariff uncertainty
Revenue
$364.49M
▼ 12.7% YoY
Diluted EPS
$2.14
Gross margin
67.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-13
Nu Skin Enterprises, Inc. (NUS) Q4 2024 Earnings Call Transcript
Balanced tone RISE segment and ecosystem strategy Latin America and developing markets growth Maybelline/Later divestiture
Revenue
$445.55M*
▼ 8.8% YoY
Gross margin
62.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Nu Skin Enterprises, Inc. (NUS) Q3 2024 Earnings Call Transcript
Cautious tone Rhyz segments and Mavely growth Cost and operational optimization Product innovation and portfolio strategy
Revenue
$430.14M
▼ 13.8% YoY
Diluted EPS
$0.17
Gross margin
70.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Nu Skin Enterprises, Inc. (NUS) Q2 2024 Earnings Call Transcript
Positive tone Enterprise transformation and Rhyz ecosystem Developing and emerging markets expansion Macroeconomic and direct selling headwinds
Revenue
$439.08M
▼ 12.2% YoY
Diluted EPS
$-2.38
▼ 540.7% YoY
Gross margin
70.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
Nu Skin Enterprises, Inc. (NUS) Q1 2024 Earnings Call Transcript
Positive tone Product Innovation Pipeline Rhyz Ecosystem & BeautyBio Channel Activation & Sales Leadership
Revenue
$417.31M
▼ 13.3% YoY
Diluted EPS
$-0.01
▼ 104.3% YoY
Gross margin
70.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-14
Nu Skin Enterprises, Inc. (NUS) Q4 2023 Earnings Call Transcript
Positive tone Rhyz ecosystem growth Digital and affiliate platform build-out Capital reallocation and dividend cut
Revenue
$488.64M*
▼ 6.5% YoY
Gross margin
72.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Nu Skin Enterprises, Inc. (NUS) Q3 2023 Earnings Call Transcript
Revenue
$498.77M
▼ 7.3% YoY
Diluted EPS
$-0.74
Gross margin
58.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-01
Nu Skin Enterprises, Inc. (NUS) Q2 2023 Earnings Call Transcript
Revenue
$500.26M
▼ 10.8% YoY
Diluted EPS
$0.54
▼ 19.4% YoY
Gross margin
72.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
Nu Skin Enterprises, Inc. (NUS) Q1 2023 Earnings Call Transcript
Revenue
$481.46M
▼ 20.4% YoY
Diluted EPS
$0.23
▼ 69.7% YoY
Gross margin
72.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-15
Nu Skin Enterprises, Inc. (NUS) Q4 2022 Earnings Call Transcript
Revenue
$522.34M*
▼ 22.4% YoY
Gross margin
71.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Nu Skin Enterprises, Inc. (NUS) Q3 2022 Earnings Call Transcript
Revenue
$537.80M
▼ 16.1% YoY
Diluted EPS
$-0.51
▼ 152.6% YoY
Gross margin
67.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-08
Nu Skin Enterprises, Inc. (NUS) Q2 2022 Earnings Call Transcript
Revenue
$560.62M
▼ 20.4% YoY
Diluted EPS
$0.67
▼ 41.7% YoY
Gross margin
73.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
Nu Skin Enterprises, Inc. (NUS) Q1 2022 Earnings Call Transcript
Revenue
$604.90M
▼ 10.7% YoY
Diluted EPS
$0.76
▼ 16.5% YoY
Gross margin
73.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-16
Nu Skin Enterprises, Inc. (NUS) Q4 2021 Earnings Call
Revenue
$673.44M*
▼ 10% YoY
Gross margin
74.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-04
Nu Skin Enterprises, Inc. (NUS) Q3 2021 Earnings Call Transcript
Revenue
$641.15M
▼ 8.8% YoY
Diluted EPS
$0.97
▼ 10.2% YoY
Gross margin
75.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Nu Skin Enterprises, Inc. (NUS) Q2 2021 Earnings Call Transcript
Revenue
$704.05M
▲ 15% YoY
Diluted EPS
$1.15
▲ 42% YoY
Gross margin
75.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Nu Skin Enterprises, Inc. (NUS) Q1 2021 Earnings Call Transcript
Revenue
$677.03M
▲ 30.7% YoY
Diluted EPS
$0.91
▲ 152.8% YoY
Gross margin
74.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-11
Nu Skin Enterprises, Inc. (NUS) Q4 2020 Earnings Call
Revenue
$748.19M*
▲ 28.3% YoY
Gross margin
74.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-04
Nu Skin Enterprises, Inc. (NUS) Q3 2020 Earnings Call Transcript
Revenue
$703.35M
▲ 19.2% YoY
Diluted EPS
$1.08
▲ 36.7% YoY
Gross margin
73.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
Nu Skin Enterprises, Inc. (NUS) Q2 2020 Earnings Call Transcript
Revenue
$612.37M
▼ 1.8% YoY
Diluted EPS
$0.81
▼ 2.4% YoY
Gross margin
74.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Nu Skin Enterprises, Inc. (NUS) Q1 2020 Earnings Call Transcript
Revenue
$518.03M
▼ 16.9% YoY
Diluted EPS
$0.36
▼ 53.2% YoY
Gross margin
75.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-12
Nu Skin Enterprises, Inc. (NUS) Q4 2019 Earnings Call
Revenue
$583.36M*
▼ 14.6% YoY
Gross margin
75.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–27 of 27 webcasts
Key facts CIK 1021561 CUSIP 67018T105 13F (30d) 4 filings 4 filers Visit website Investor relations